hormone therapy

Hormone Therapy? No to Prevent Disease, Yes to Ease Menopause Woes

Published October 3, 2013

Hormone Therapy? No To Prevent Disease, Yes To Ease Menopause Woes
Yes, Dr. Manson said, “If a woman is at very high risk of cardiovascular disease — if she's had a prior stroke or blood clots in her legs or… Continue reading →

Randomized Trials Built on Sand: Examples From COPD, Hormone Therapy, and Cancer.

Published August 4, 2013

Randomized Trials Built on Sand: Examples from COPD, Hormone Therapy, and Cancer.

Rambam Maimonides Med J. 2012 Jul; 3(3): e0014
Suissa S

The randomized controlled trial is the fundamental study design to evaluate the effectiveness of medications and receive… Continue reading →

On the Record: Bill Galvin Segment 1

Published July 11, 2013

On The Record: Bill Galvin Segment 1 – Watch this week’s On The Record.

A problem shared really IS a problem halved : Talking about worries releases …
Treating depression with the 'cuddle' hormone oxytocin could help patients… Continue reading →

Postradiation Osteosarcoma in an Older Prostate Cancer Survivor: Case Study and Literature Review With Emphasis on Geriatric Principles.

Published June 7, 2013

Postradiation osteosarcoma in an older prostate cancer survivor: case study and literature review with emphasis on geriatric principles.

Case Rep Oncol. 2013 May; 6(2): 250-5
Gumber D, Rodin M, Wildes TM

The aging population and the increasing number of… Continue reading →

Do Hormone Treatments for Prostate Cancer Cause Anxiety and Depression?

Published June 4, 2013

Do hormone treatments for prostate cancer cause anxiety and depression?

Int J Clin Oncol. 2013 Jun 1;
Sharpley CF, Christie DR, Bitsika V

BACKGROUND: To investigate the relationship between hormone therapy (HT) and incidence of anxiety and depression among… Continue reading →

Propofol for Procedural Sedation in the Emergency Department: A Qualitative Systematic Review (June).

Published May 23, 2013

Propofol for Procedural Sedation in the Emergency Department: A Qualitative Systematic Review (June).

Ann Pharmacother. 2013 May 21;
Black E, Campbell SG, Magee K, Zed PJ

OBJECTIVE:To evaluate the efficacy and safety of propofol compared to other agents for… Continue reading →

What Works in Secondary Schools? a Systematic Review of Classroom-Based Body Image Programs.

Published May 21, 2013

What works in secondary schools? A systematic review of classroom-based body image programs.

Body Image. 2013 May 14;
Yager Z, Diedrichs PC, Ricciardelli LA, Halliwell E

Governments, schools, and curriculum authorities are increasingly recognizing that body image during adolescence… Continue reading →

Dihydropyrimidinase Deficiency: The First Feline Case of Dihydropyrimidinuria With Clinical and Molecular Findings.

Published February 23, 2013

Dihydropyrimidinase deficiency: the first feline case of dihydropyrimidinuria with clinical and molecular findings.

JIMD Rep. 2012; 6: 21-6
Chang HS, Shibata T, Arai S, Zhang C, Yabuki A, Mitani S, Higo T, Sunagawa K, Mizukami K, Yamato O

Dihydropyrimidinase (DHP, EC 3.5.2.2) is the second enzyme of the pyrimidine degradation pathway and a deficiency of this enzyme is responsible for a rare inborn metabolic syndrome characterized by dihydropyrimidinuria. Here we report a cat with DHP deficiency, manifesting malnutrition, depression, vomiting, and hyperammonemia. A gas chromatographic-mass spectrometric analysis of urinary metabolic substances showed the presence of large amounts of dihydrouracil and dihydrothymine and moderate amounts of uracil and thymine, suggesting DHP deficiency. Analysis of the feline DPYS gene encoding DHP demonstrated that the cat was homozygous for the missense mutation c.1303G>A… Continue reading →

Striatal Glutamate Release in L-DOPA-Induced Dyskinetic Animals.

Published February 8, 2013

Striatal Glutamate Release in l-DOPA-Induced Dyskinetic Animals.

Filed under: Drug and Alcohol Rehabilitation

PLoS One. 2013; 8(2): e55706
Nevalainen N, Lundblad M, Gerhardt GA, Strömberg I

l-DOPA-induced dyskinesia is a common side effect developed after chronic treatment with 3,4-dihydroxyphenyl-l-alanine… Continue reading →

Drug and Alcohol Rehabilitation: In Vivo Targeting of ADAM9 Gene Expression Using Lentivirus-Delivered shRNA Suppresses Prostate Cancer Growth by Regulating REG4 Dependent Cell Cycle Progression.

Published January 25, 2013

In Vivo Targeting of ADAM9 Gene Expression Using Lentivirus-Delivered shRNA Suppresses Prostate Cancer Growth by Regulating REG4 Dependent Cell Cycle Progression.